Keytruda backed for monotherapy treatment but combination therapy rejected
News
Gilead’s COVID-19 drug remdesivir bags US approval
Antiviral becomes first COVID-19 treatment approved in the US
STORM Therapeutics’ METTL3 inhibitor moves closer to the clinic
First-in-class drug candidate selected for development
Valneva bags positive phase II results for Lyme disease vaccine
Investigational vaccine candidate was generally safe across all dose and age groups
Pharming’s APDS drug scores EU orphan status
European commission grants leniolisib orphan drug designation
Epsilogen awarded £1m grant from Innovate UK
Funding will be used to develop novel IgE antibodies to treat cancer
New research highlights Northern Ireland’s ‘thriving’ life sciences sector
Pharmaceutical and life sciences industries are growing in importance across country
Asthma fund launched to support development and adoption of new technologies
Asthma Technology Fund launched with £3m+ funding
Public urged to follow COVID-19 rules as concerns grow over long-term impact of virus
New film and study highlight the effects of ‘long COVID’
GSK’s RSV vaccine candidates score positive phase I/II results
Vaccine candidates prove promising for maternal immunisation and for older adults
AZ’s Tagrisso scores priority review from FDA
Agency will review drug for the treatment of early-stage EGFR-mutated lung cancer
Aimmune’s peanut allergy med moves toward EU approval
CHMP grants Palforzia a positive opinion for the treatment of peanut allergic patients
FDA accepts review for ANGLE’s Parsortix system for metastatic breast cancer
System captures and harvests intact circulating tumour cells for analysis
Experts partner with UK government for COVID-19 human challenge trials
NHS, academia and private sector join forces to explore and establish trials
UCB acquires new campus to support UK operations
Following completion of acquisition, site will undergo refurbishment
